01303nas a2200457   4500000000100000000000100001000000100002008004100003653001100044653005000055653002800105653003200133653005200165653002800217653002600245653004000271653001500311653001900326100001400345700001500359700001500374700001400389700001500403700001700418700001400435700001700449700001200466700001700478700001300495700002200508700001500530700001800545700001500563700001400578700001600592245017300608250001500781300001000796490000700806020003200813       2023                            d10aHumans10a*Acute Coronary Syndrome/drug therapy/surgery10aAspirin/adverse effects10aClopidogrel/therapeutic use10aPlatelet Aggregation Inhibitors/adverse effects10aPrasugrel Hydrochloride10aRetrospective Studies10a*ST Elevation Myocardial Infarction10aTicagrelor10aCohort Studies1 aJ. Harris1 aK. Pouwels1 aT. Johnson1 aJ. Sterne1 aC. Pithara1 aK. Mahadevan1 aB. Reeves1 aU. Benedetto1 aY. Loke1 aD. Lasserson1 aB. Doble1 aN. Hopewell-Kelly1 aS. Redwood1 aS. Wordsworth1 aA. Mumford1 aC. Rogers1 aM. Pufulete00aBleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies  a2023/07/12  a1-2570 v27  a1366-5278 (Print)
1366-5278